{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:50:21Z","timestamp":1771339821273,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21672092"],"award-info":[{"award-number":["21672092"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21877056"],"award-info":[{"award-number":["21877056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["80273091"],"award-info":[{"award-number":["80273091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872253"],"award-info":[{"award-number":["81872253"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["ZYAOX2018009"],"award-info":[{"award-number":["ZYAOX2018009"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bcp.2022.115049","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T20:24:13Z","timestamp":1650659053000},"page":"115049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Design and synthesis of novel 7-ethyl-10-fluoro-20-O-(cinnamic acid ester)-camptothecin derivatives as potential high selectivity and low toxicity topoisomerase I inhibitors for hepatocellular carcinoma"],"prefix":"10.1016","volume":"200","author":[{"given":"Yin-Peng","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong-Fei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2022.115049_b0005","doi-asserted-by":"crossref","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71 (2021) 209-249.","DOI":"10.3322\/caac.21660"},{"key":"10.1016\/j.bcp.2022.115049_b0010","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejps.2018.08.018","article-title":"Two novel camptothecin derivatives inhibit colorectal cancer proliferation via induction of cell cycle arrest and apoptosis in vitro and in vivo","volume":"123","author":"Du","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2022.115049_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113555","article-title":"Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets","volume":"220","author":"Lauria","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmech.2019.03.034","article-title":"A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade","volume":"171","author":"Liang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0025","doi-asserted-by":"crossref","unstructured":"T.G. Burke, Chemistry of the camptothecins in the bloodstream: Drug stabilization and optimization of activity. In Annals of the New York Academy of Sciences; The camptothecins: From discovery to the patient. 803 (1996) 29-31.","DOI":"10.1111\/j.1749-6632.1996.tb26373.x"},{"key":"10.1016\/j.bcp.2022.115049_b0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/med.21342","article-title":"Perspectives on Biologically Active Camptothecin Derivatives","volume":"35","author":"Liu","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2022.115049_b0035","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.2174\/138161208784246180","article-title":"Design, synthesis and development of novel camptothecin drugs","volume":"14","author":"Liew","year":"2008","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/j.bcp.2022.115049_b0040","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1016\/j.phytochem.2004.09.001","article-title":"Molecules of interest - Camptothecin, over four decades of surprising findings","volume":"65","author":"Lorence","year":"2004","journal-title":"Phytochemistry"},{"issue":"6","key":"10.1016\/j.bcp.2022.115049_b0045","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bcp.2007.10.016","article-title":"Next generation topoisomerase I inhibitors: Rationale and biomarker strategies","volume":"75","author":"Teicher","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115049_b0050","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1021\/acs.jmedchem.7b01297","article-title":"Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes","volume":"61","author":"Das","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2019.01.016","article-title":"Redox\/pH dual-stimuli responsive camptothecin prodrug nanogels for \u201con-demand\u201d drug delivery","volume":"296","author":"Qu","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2022.115049_b0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2013.07.022","article-title":"Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38","volume":"172","author":"Bala","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2022.115049_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11095-017-2278-0","article-title":"Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer","volume":"35","author":"Mohammad","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bcp.2022.115049_b0070","first-page":"32","article-title":"Irinotecan for the treatment of cervical cancer","volume":"16","author":"Verschraegen","year":"2002","journal-title":"Oncology-N. Y."},{"key":"10.1016\/j.bcp.2022.115049_b0075","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1914510","article-title":"Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer","volume":"382","author":"Modi","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bcp.2022.115049_b0080","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1470-2045(19)30097-X","article-title":"Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study","volume":"20","author":"Tamura","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2022.115049_b0085","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejmech.2019.02.017","article-title":"Antibody-drug conjugates of 7-ethyl-10-hydroxycamptothecin: Sacituzumab govitecan and labetuzumab govitecan","volume":"167","author":"Dong","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0090","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/13543784.2020.1792443","article-title":"Trastuzumab-deruxtecan: an investigational agent for the treatment of HER2-positive breast cancer","volume":"29","author":"Bartsch","year":"2020","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.bcp.2022.115049_b0095","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2174\/156802606777951109","article-title":"Fluorinated natural products with clinical significance","volume":"6","author":"Thomas","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0100","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of Fluorine in Medicinal Chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0105","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ejca.2007.01.014","article-title":"Bone Sarcoma, Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II\u2013study of the EORTC Soft Tissue and Bone Sarcoma Group","volume":"43","author":"Reichardt","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2022.115049_b0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0169-5002(03)00190-9","article-title":"Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancer","volume":"41","author":"Braybrooke","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2022.115049_b0115","unstructured":"K.L Annette, G. Criste\u2018le, C. Ginette, Y.P. Sergey, N. Irina, L. Olivier, L.G. Laurence, H.B. C. Dennis, Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells. Cancer Res. 61 (2001) 2961-2967."},{"key":"10.1016\/j.bcp.2022.115049_b0120","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1021\/jm400906z","article-title":"A New Strategy To Improve the Metabolic Stability of Lactone: Discovery of (20S,21S)-21-Fluorocamptothecins as Novel, Hydrolytically Stable Topoisomerase I Inhibitors","volume":"56","author":"Miao","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0125","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1016\/j.bmcl.2017.09.012","article-title":"Design, semisynthesis and potent cytotoxic activity of novel 10-fluorocamptothecin derivatives","volume":"27","author":"Yang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2022.115049_b0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jat.2550040602","article-title":"The occurrence, metabolism and toxicity of cinnamic acid and related compounds","volume":"4","author":"Hoskins","year":"1984","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.bcp.2022.115049_b0135","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1021\/jf0729098","article-title":"Structure-Antifungal Activity Relationship of Cinnamic Acid Derivatives","volume":"55","author":"Bisogno","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0140","doi-asserted-by":"crossref","unstructured":"C.f. Yang, Y. Zhou, Y. Zheng, C.L. Li, S. Sheng, J. Wang, F.A. Wu, Enzymatic modification of chitosan by cinnamic acids: Antibacterial activity against Ralstonia solanacearum. Int. J. Biol. Macromol. 87 (2016) 577-585.","DOI":"10.1016\/j.ijbiomac.2016.03.023"},{"key":"10.1016\/j.bcp.2022.115049_b0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jdermsci.2018.01.004","article-title":"Yang, Trans -cinnamic acid attenuates UVA-induced photoaging through inhibition of AP-1 activation and induction of Nrf2-mediated antioxidant genes in human skin fibroblasts","volume":"90","author":"Hseu","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bcp.2022.115049_b0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.antiviral.2017.07.018","article-title":"Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress","volume":"145","author":"Amano","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bcp.2022.115049_b0155","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejmech.2015.01.040","article-title":"Synthesis, in vitro and in vivo antitumor activity of scopoletin-cinnamic acid hybrids","volume":"93","author":"Li","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0160","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1016\/j.bmc.2010.06.003","article-title":"Synthesis, molecular modeling, and biological evaluation of cinnamic acid metronidazole ester derivatives as novel anticancer agents","volume":"18","author":"Qian","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0165","doi-asserted-by":"crossref","first-page":"8700","DOI":"10.1021\/jm101249z","article-title":"Antitumor Agents 286. Design, Synthesis and Structure-Activity Relationships of 3\u2032R,4\u2032R-Disubstituted-2\u2032,2\u2032-dimethyldihydropyrano[2,3-f]chromone (DSP) Analogs as Potent Chemosensitizers to Overcome Multidrug Resistance","volume":"53","author":"Zhou","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105511","article-title":"Cinnamic acid derivatives as chemosensitising agents against DOX-treated lung cancer cells - Involvement of carbonyl reductase 1","volume":"154","author":"Koczurkiewicz-Adamczyk","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2022.115049_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2019.108499","article-title":"New cinnamic acid-pregenolone hybrids as potential antiproliferative agents: Design, synthesis and biological evaluation","volume":"152","author":"Ge","year":"2019","journal-title":"Steroids"},{"key":"10.1016\/j.bcp.2022.115049_b0180","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1021\/jo000221n","article-title":"20-O-acylcamptothecin derivatives: evidence for lactone stabilization","volume":"65","author":"Zhao","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0185","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.24736","volume":"55","author":"Ho","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2022.115049_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111971","article-title":"Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin","volume":"187","author":"Yang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0195","doi-asserted-by":"crossref","first-page":"113639","DOI":"10.1016\/j.ejmech.2021.113639","article-title":"Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise","volume":"223","author":"Khaiwa","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0200","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1021\/acs.jmedchem.8b01938","article-title":"Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity","volume":"62","author":"Kundu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115049_b0205","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3390\/cancers11121964","article-title":"(S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity","volume":"11","author":"Song","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2022.115049_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113716","article-title":"RJT-101, a novel camptothecin derivative, is highly effective in the treatment of melanoma through DNA damage by targeting topoisomerase 1","volume":"171","author":"Lian","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115049_b0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1517\/14728222.6.1.73","article-title":"Targeting apoptosis in cancer chemotherapy","volume":"6","author":"Makin","year":"2002","journal-title":"Expert. Opin. Ther. Targets"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:11:33Z","timestamp":1762096293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":43,"alternative-id":["S0006295222001435"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115049","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of novel 7-ethyl-10-fluoro-20-O-(cinnamic acid ester)-camptothecin derivatives as potential high selectivity and low toxicity topoisomerase I inhibitors for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115049"}}